Senores Pharmaceuticals Limited
SENORES

Senores Pharmaceuticals Limited

Pharmaceuticals
Share price
₹1,091
Market cap
₹5,026 Cr
1Y return
▲ 32%

A pharmaceutical manufacturer that produces complex generic medicines certified by global regulatory authorities including the FDA and WHO. Incorporated in 2015, the company focuses on developing and supplying affordable, high-quality pharmaceutical formulations to domestic and international markets. Its operations center on manufacturing specialized generics that address critical therapeutic areas while maintaining stringent international quality standards and compliance requirements.

Investors holding Senores Pharmaceuticals Limited

HSBC Mutual Fund
HSBC Mutual Fund
Mutual Fund
2.87%
AC
Astorne Capital
Foreign Investor
1.36%
1.23%

Recent moves 13

Moves13
4newest moves
Members only

Including 1 new position

Unlock all 4 moves
HSBC Mutual FundDecreased
HSBC Mutual Fund reduced its stake in Senores Pharmaceuticals Limited from 3.44% to 2.87%, selling 2,62,802 shares.
16 Oct 2026
Read more
Mahindra Manulife Mutual FundIncreased
Mahindra Manulife Mutual Fund increased its stake in Senores Pharmaceuticals from 1.14% to 1.21%, buying 31,937 shares.
16 Oct 2026
Read more
ICICI Prudential Mutual FundExited
ICICI Prudential Mutual Fund, which previously held 1.37 percent of Senores Pharmaceuticals Limited, has dropped off the company's disclosed shareholder list, indicating either a complete exit or a reduction below the 1 percent reporting threshold.
20 Jul 2026
Read more
Aditya Birla Sun Life InsuranceDecreased
Aditya Birla Sun Life Insurance reduced its stake in Senores Pharmaceuticals from 2.96% to 1.62% by selling 617,002 shares.
20 Jul 2026
Read more
Astorne CapitalIncreased
Astorne Capital increased its stake in Senores Pharmaceuticals from 1.53% (705,346 shares) to 1.95% (897,350 shares), acquiring an additional 192,004 shares.
20 Jul 2026
Read more
HSBC Mutual FundIncreased
HSBC Mutual Fund increased its stake in Senores Pharmaceuticals Limited from 2.29% to 3.44% by acquiring 527,314 additional shares.
20 Jul 2026
Read more
Mahindra Manulife Mutual FundDecreased
Mahindra Manulife Mutual Fund decreased its stake in Senores Pharmaceuticals Limited from 1.40% to 1.14%, selling 123,337 shares.
20 Jul 2026
Read more
Bajaj Finserv Mutual FundNew position
Bajaj Finserv Mutual Fund acquired 5,48,914 shares of Senores Pharmaceuticals Limited, representing a 1.19% stake.
20 Jul 2026
Read more
5 promotersIncreased
Five promoters of Senores Pharmaceuticals acquired 11.7 lakh shares for ₹95.01 Cr at ₹812.00 apiece, bringing the promoter group's total stake in the company to 63.16%.
28 Mar 2026
Read more

Track the whales in Senores Pharmaceuticals Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1